• Nirmatrelvir (PF-07321332): Reliable SARS-CoV-2 Inhibition i

  2026-07-01

  This in-depth guide explores how Nirmatrelvir (PF-07321332), available as SKU B8579, addresses key reproducibility, assay compatibility, and data interpretation challenges in SARS-CoV-2 replication research. Scenario-driven Q&As provide practical, evidence-based advice for biomedical researchers seeking robust small-molecule solutions for COVID-19 antiviral studies.

• 3D Nanotube-in-Micropillar Arrays Enable Size-Independent Bl

  2026-06-30

  This study presents a 3D nanotube-in-micropillar array electrode system that enables efficient electroporation and genetic probe delivery across heterogeneous blood cell populations. The approach circumvents size and orientation limitations of conventional electroporation, potentially streamlining non-viral transfection workflows for cell and gene therapy applications.

• Melittin: Bioactive Peptide Workflows for Signal Transductio

  2026-06-30

  Melittin, a potent bioactive peptide, empowers researchers to dissect G protein-coupled receptor signaling with unmatched specificity. This guide details optimized protocols, troubleshooting, and real-world insights—bridging literature breakthroughs to practical lab execution.

• Optimizing Cell Assays with High-Purity Arctigenin (SKU N239

  2026-06-29

  This article delivers practical, scenario-driven guidance on using Arctigenin (SKU N2399) to enhance cell viability, proliferation, and cytotoxicity assays. By addressing reproducibility, mechanistic precision, and vendor reliability, it demonstrates how APExBIO’s Arctigenin supports robust experimental outcomes for biomedical researchers.

• Flubendazole in Autophagy Modulation: Protocols & Assay Inno

  2026-06-29

  Flubendazole empowers autophagy signaling investigation in cancer and neurodegenerative research, offering DMSO-based solubility and robust reproducibility. This guide details stepwise protocols, optimized troubleshooting, and insights from recent breast cancer mechanistic studies to maximize your autophagy modulation research.

• Patient-Derived Gastric Cancer Assembloids Reveal Stromal Im

  2026-06-28

  This study pioneers a patient-derived gastric cancer assembloid model integrating matched tumor organoids with stromal cell subpopulations, enabling physiologically relevant analysis of tumor-stroma interactions. The model demonstrates that stromal components profoundly influence gene expression and drug sensitivity, informing more predictive preclinical research and personalized therapeutic strategies.

• Nicotinamide Adenine Dinucleotide (NAD+): Applied Research W

  2026-06-27

  Unlock the full potential of Nicotinamide Adenine Dinucleotide (NAD+) in metabolic signaling and autophagy research with APExBIO's high-purity reagent. This guide details experimental workflows, troubleshooting strategies, and the latest mechanistic insights—enabling researchers to design robust, next-generation assays.

• Glucocorticoid-Induced Modulation of CaV1.2 and Kv2.1 in Hip

  2026-06-26

  This study reveals that glucocorticoids rapidly suppress CaV1.2-mediated calcium signaling in hippocampal neurons by promoting endocytosis of Kv2.1 channel clusters via a cAMP/PKA-dependent mechanism. These findings clarify a previously unclear nongenomic pathway by which stress hormones acutely modulate neuronal excitability, with implications for understanding stress responses in the brain.

• BMX-IN-1: Precision BMX Kinase Inhibitor for Advanced Workfl

  2026-06-26

  BMX-IN-1, a highly selective and irreversible BMX kinase inhibitor from APExBIO, enables researchers to dissect cellular signaling relevant to cancer and host-pathogen interactions. This article details actionable workflows, protocol optimizations, and troubleshooting approaches for maximizing experimental success with BMX-IN-1 across cancer biology and infection models.

• Intra- and Extracellular Dicloxacillin Activity Against MSSA

  2026-06-25

  This article reviews a pivotal study that rigorously characterizes the intra- and extracellular efficacy of dicloxacillin against methicillin-sensitive Staphylococcus aureus (MSSA), using both in vitro and in vivo models. The research identifies key pharmacodynamic indices that predict antibiotic performance and highlights implications for Gram-positive infection research and assay design.

• Technical Guide: DiI (DiIC18(3)) Plasma Membrane Orange Prob

  2026-06-25

  DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe enables selective, high-contrast labeling of cell plasma membranes, supporting applications like neuronal tracing and cell migration assays where membrane specificity is critical. It is not suitable for water-based protocols or for labeling intracellular organelles. Researchers should adhere to solvent compatibility and membrane-targeted workflows to ensure reproducibility.

• KR-12 Peptide Origami: Innovations Against Drug-Resistant Ba

  2026-06-24

  The referenced review presents the rational design and application of KR-12-derived antimicrobial peptides—compact, low-toxicity molecules engineered for enhanced potency and stability. These advances position KR-12 constructs as promising candidates for eradicating drug-resistant pathogens and biofilms, with broad implications for antibiotic resistance research and therapeutic development.

• Scenario-Driven Solutions with Angiotensin I (human, mouse,

  2026-06-23

  This article presents five scenario-based Q&A blocks addressing real challenges in cell viability, proliferation, and cytotoxicity assays using Angiotensin I (human, mouse, rat) (SKU A1006). Drawing on validated protocols and evidence, it demonstrates how this decapeptide enhances reproducibility, sensitivity, and workflow confidence for renin-angiotensin system research. Practical insights are provided for researchers, lab technicians, and postgraduates seeking robust data and reliable vendor selection.

• GLT-1 Upregulation Mitigates TBI via CB1-CREB Pathway Inhibi

  2026-06-23

  This study demonstrates that enhancing GLT-1 expression reduces neuronal apoptosis and cognitive dysfunction after traumatic brain injury (TBI) by inhibiting the CB1-CREB signaling pathway. These findings clarify the mechanistic link between endocannabinoid signaling and glutamate homeostasis, offering a targeted strategy for neuroprotection in TBI models.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Precision in mRNA Delivery

  2026-06-22

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) enables dual-fluorescent tracking of mRNA delivery and translation efficiency in live cells. Its Cap 1 structure, 5-methoxyuridine modification, and Cy5 labeling provide robust immune evasion and direct visualization. This APExBIO product advances quantitative gene regulation studies and nanoparticle validation workflows.

453 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page